nandrolone has been researched along with mifepristone in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Joosten, JW; Kloosterboer, HJ; Schoonen, WG | 1 |
| Kanzaki, H; Nakajima, T; Okada, H; Yasuda, K; Yoshimura, T | 1 |
| MacBride, MM; Muddana, SS; Peterson, BR; Price, AM | 1 |
| Borja-Cacho, E; Cooney, AJ; García-Becerra, R; Larrea, F; Lemus, AE; Pérez-Palacios, G; Smith, CL | 1 |
| Hashiba, M; Ichioka, M; Kyo, S; Mita, S; Miyazaki, H; Nakakuki, M; Shimizu, Y | 1 |
6 other study(ies) available for nandrolone and mifepristone
| Article | Year |
|---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: II. T47D cell lines.
Topics: Breast Neoplasms; Carcinoma; Cell Division; Desogestrel; Dose-Response Relationship, Drug; Estradiol; Estrenes; Estrogen Antagonists; Female; Furans; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Mifepristone; Nandrolone; Norethindrone; Norpregnenes; Pregnanes; Pregnenediones; Progesterone; Promegestone; Tumor Cells, Cultured | 1995 |
The inhibitory effect of dienogest, a synthetic steroid, on the growth of human endometrial stromal cells in vitro.
Topics: Cell Division; Cells, Cultured; Contraceptives, Oral; Endometrium; Estradiol; Female; Hormone Antagonists; Humans; Mifepristone; Molecular Structure; Nandrolone; Progesterone; Prolactin; Steroids | 2001 |
11beta-alkyl-Delta9-19-nortestosterone derivatives: high-affinity ligands and potent partial agonists of the androgen receptor.
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Animals; Antineoplastic Agents; Cell Line, Tumor; CHO Cells; Cricetinae; Cyproterone Acetate; Dimerization; Humans; Ligands; Male; Mifepristone; Nandrolone; Prostatic Neoplasms; Receptors, Androgen; Structure-Activity Relationship | 2004 |
Synthetic 19-nortestosterone derivatives as estrogen receptor alpha subtype-selective ligands induce similar receptor conformational changes and steroid receptor coactivator recruitment than natural estrogens.
Topics: Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Fulvestrant; HeLa Cells; Histone Acetyltransferases; Humans; Mifepristone; Nandrolone; Nuclear Receptor Coactivator 1; Progesterone; Progestins; Protein Conformation; Receptors, Progesterone; Receptors, Steroid; Recombinant Proteins; Transcription Factors; Transfection; Trypsin | 2006 |
Dienogest inhibits C-C motif chemokine ligand 20 expression in human endometriotic epithelial cells.
Topics: Cell Line; Chemokine CCL20; Endometriosis; Epithelial Cells; Female; Humans; Interleukin-1beta; Mifepristone; Nandrolone; Receptors, Progesterone | 2017 |